Javascript must be enabled to continue!
Risk Factors of Cardiovascular Diseases on Patients with Cardiovascular Diseases
View through CrossRef
Cardiovascular diseases (CVD) are the leading cause of death globally and the main problem of non-communicable diseases. Prevention is part of cardiovascular disease treatment because it breaks the chain of management and subsequent complications from the disease. Its foundation is based on the promotion of a healthy lifestyle, as well as appropriate identification and treatment for cardiovascular risk factors. This study aimed to identify risk factors for cardiovascular diseases in patients with cardiovascular diseases. A descriptive study was performed with proportionate stratified random sampling and 88 patients with cardiovascular diseases participated in this study. Data were collected in one of general hospitals in Pekanbaru, Indonesia. The risk factors of cardiovascular disease patients were assessed using a questionnaire. Descriptive analysis statistic was used to describe risk factors of cardiovascular disease. Moreover, 80% of patients completed the questionnaire. The results showed that the majority of respondents (56.8%) had hypercholesterolemia. The results showed that most respondents (73) had a smoking history (83%). The result showed that most of the patients (64.8%) with cardiovascular disease have no family history of heart attacks. The result showed that the majority of the respondents (69.3%) had a family history of hypertension. Over 92% of respondents were unable to do strenuous activities and 79.5% were unable to do moderate activities even once a week. Early assessment and education about risk factors of cardiovascular diseases are important for the prevention and promotion of health.
Keywords: cardiovascular disease, cardiac patients, activity patterns
Title: Risk Factors of Cardiovascular Diseases on Patients with Cardiovascular Diseases
Description:
Cardiovascular diseases (CVD) are the leading cause of death globally and the main problem of non-communicable diseases.
Prevention is part of cardiovascular disease treatment because it breaks the chain of management and subsequent complications from the disease.
Its foundation is based on the promotion of a healthy lifestyle, as well as appropriate identification and treatment for cardiovascular risk factors.
This study aimed to identify risk factors for cardiovascular diseases in patients with cardiovascular diseases.
A descriptive study was performed with proportionate stratified random sampling and 88 patients with cardiovascular diseases participated in this study.
Data were collected in one of general hospitals in Pekanbaru, Indonesia.
The risk factors of cardiovascular disease patients were assessed using a questionnaire.
Descriptive analysis statistic was used to describe risk factors of cardiovascular disease.
Moreover, 80% of patients completed the questionnaire.
The results showed that the majority of respondents (56.
8%) had hypercholesterolemia.
The results showed that most respondents (73) had a smoking history (83%).
The result showed that most of the patients (64.
8%) with cardiovascular disease have no family history of heart attacks.
The result showed that the majority of the respondents (69.
3%) had a family history of hypertension.
Over 92% of respondents were unable to do strenuous activities and 79.
5% were unable to do moderate activities even once a week.
Early assessment and education about risk factors of cardiovascular diseases are important for the prevention and promotion of health.
Keywords: cardiovascular disease, cardiac patients, activity patterns.
Related Results
Rethinking Anticoagulation in Kidney Disease and Kidney Transplantation
Rethinking Anticoagulation in Kidney Disease and Kidney Transplantation
BackgroundA clinical dilemma exists in patients with CKD, ESKD, and after kidney transplantation, as they face concurrent risks of both thromboembolic and hemorrhagic complications...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Platform Session B: Clinical Neurophysiology/Clinical Epilepsy
3:00 p.m.–6:00 p.m.
Platform Session B: Clinical Neurophysiology/Clinical Epilepsy
3:00 p.m.–6:00 p.m.
1
Jose F.
Tellez‐Zenteno,
1
Scott B.
Patten, and
1
Samuel
Wiebe
...
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Abstract
Introduction
Immunoglobulin G4-related disease (IgG4-RD) is a recently identified immune-mediated condition that is debilitating and often overlooked. While IgG4-RD has be...
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract
A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...
Clinical Profile and Surgical Outcomes of Pediatric Umbilical Pilonidal Sinus
Clinical Profile and Surgical Outcomes of Pediatric Umbilical Pilonidal Sinus
Abstract
Introduction
Umbilical pilonidal sinus (UPS) is a rare form of pilonidal disease (PNS) predominantly affecting young individuals. Owing to its low incidence, data on risk ...
Prevalence and Outcomes of Cardiovascular Diseases in Patients with COVID-19: A Research Letter
Prevalence and Outcomes of Cardiovascular Diseases in Patients with COVID-19: A Research Letter
Introduction
A higher prevalence of cardiovascular diseases among COVID-19 with positive troponin levels was initially observed in China beginning of the pandemic era. We are tryin...
Risk factors cardiovascular diseases in the population of young adults
Risk factors cardiovascular diseases in the population of young adults
Abstract
Introduction
In population of young adults it seems reasonable to assess the classical risk factors for atherosclerosis...

